 | • レポートコード：D0804-14714 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、104ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、アルファサラセミアの世界市場を広く調査・分析し、今後の市場展望をまとめております。アルファサラセミアの種類別市場規模（鉄キレート剤、遺伝子治療）、用途別市場規模（病院、民間クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Bluebird Bio、Acceleron Pharma、Novartis、Kiadis Pharma ・地域別グローバル市場分析 2015年-2020年 ・アルファサラセミアの北米市場（アメリカ、カナダ、メキシコ） ・アルファサラセミアのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・アルファサラセミアのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・アルファサラセミアの南米市場（ブラジル、アルゼンチン） ・アルファサラセミアの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：鉄キレート剤、遺伝子治療 ・用途別分析：病院、民間クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Alpha Thalassemia market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Alpha Thalassemia market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Alpha Thalassemia market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Alpha Thalassemia market has been segmented into:
Iron Chelating Drugs
Gene Therapy
By Application, Alpha Thalassemia has been segmented into:
Hospitals
Private clinics
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Alpha Thalassemia market presented in the report. This section sheds light on the sales growth of different regional and country-level Alpha Thalassemia markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Alpha Thalassemia market.
The report offers in-depth assessment of the growth and other aspects of the Alpha Thalassemia market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Alpha Thalassemia Market Share Analysis
Alpha Thalassemia competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Alpha Thalassemia sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Alpha Thalassemia sales, revenue and market share for each player covered in this report.
The major players covered in Alpha Thalassemia are:
Bluebird Bio
Acceleron Pharma
Novartis
Kiadis Pharma
Table of Contents
1 Alpha Thalassemia Market Overview
1.1 Product Overview and Scope of Alpha Thalassemia
1.2 Classification of Alpha Thalassemia by Type
1.2.1 Global Alpha Thalassemia Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Alpha Thalassemia Revenue Market Share by Type in 2019
1.2.3 Iron Chelating Drugs
1.2.4 Gene Therapy
1.3 Global Alpha Thalassemia Market by Application
1.3.1 Overview: Global Alpha Thalassemia Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Private clinics
1.3.4 Other
1.4 Global Alpha Thalassemia Market by Regions
1.4.1 Global Alpha Thalassemia Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Alpha Thalassemia (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Alpha Thalassemia Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Alpha Thalassemia Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Alpha Thalassemia Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Alpha Thalassemia Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Alpha Thalassemia Status and Prospect (2015-2025)
2 Company Profiles
2.1 Bluebird Bio
2.1.1 Bluebird Bio Details
2.1.2 Bluebird Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bluebird Bio SWOT Analysis
2.1.4 Bluebird Bio Product and Services
2.1.5 Bluebird Bio Alpha Thalassemia Revenue, Gross Margin and Market Share (2018-2019)
2.2 Acceleron Pharma
2.2.1 Acceleron Pharma Details
2.2.2 Acceleron Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Acceleron Pharma SWOT Analysis
2.2.4 Acceleron Pharma Product and Services
2.2.5 Acceleron Pharma Alpha Thalassemia Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Alpha Thalassemia Revenue, Gross Margin and Market Share (2018-2019)
2.4 Kiadis Pharma
2.4.1 Kiadis Pharma Details
2.4.2 Kiadis Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Kiadis Pharma SWOT Analysis
2.4.4 Kiadis Pharma Product and Services
2.4.5 Kiadis Pharma Alpha Thalassemia Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Alpha Thalassemia Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Alpha Thalassemia Players Market Share
3.2.2 Top 10 Alpha Thalassemia Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Alpha Thalassemia Revenue and Market Share by Regions
4.2 North America Alpha Thalassemia Revenue and Growth Rate (2015-2020)
4.3 Europe Alpha Thalassemia Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Alpha Thalassemia Revenue and Growth Rate (2015-2020)
4.5 South America Alpha Thalassemia Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Alpha Thalassemia Revenue and Growth Rate (2015-2020)
5 North America Alpha Thalassemia Revenue by Countries
5.1 North America Alpha Thalassemia Revenue by Countries (2015-2020)
5.2 USA Alpha Thalassemia Revenue and Growth Rate (2015-2020)
5.3 Canada Alpha Thalassemia Revenue and Growth Rate (2015-2020)
5.4 Mexico Alpha Thalassemia Revenue and Growth Rate (2015-2020)
6 Europe Alpha Thalassemia Revenue by Countries
6.1 Europe Alpha Thalassemia Revenue by Countries (2015-2020)
6.2 Germany Alpha Thalassemia Revenue and Growth Rate (2015-2020)
6.3 UK Alpha Thalassemia Revenue and Growth Rate (2015-2020)
6.4 France Alpha Thalassemia Revenue and Growth Rate (2015-2020)
6.5 Russia Alpha Thalassemia Revenue and Growth Rate (2015-2020)
6.6 Italy Alpha Thalassemia Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Alpha Thalassemia Revenue by Countries
7.1 Asia-Pacific Alpha Thalassemia Revenue by Countries (2015-2020)
7.2 China Alpha Thalassemia Revenue and Growth Rate (2015-2020)
7.3 Japan Alpha Thalassemia Revenue and Growth Rate (2015-2020)
7.4 Korea Alpha Thalassemia Revenue and Growth Rate (2015-2020)
7.5 India Alpha Thalassemia Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Alpha Thalassemia Revenue and Growth Rate (2015-2020)
8 South America Alpha Thalassemia Revenue by Countries
8.1 South America Alpha Thalassemia Revenue by Countries (2015-2020)
8.2 Brazil Alpha Thalassemia Revenue and Growth Rate (2015-2020)
8.3 Argentina Alpha Thalassemia Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Alpha Thalassemia by Countries
9.1 Middle East & Africa Alpha Thalassemia Revenue by Countries (2015-2020)
9.2 Saudi Arabia Alpha Thalassemia Revenue and Growth Rate (2015-2020)
9.3 UAE Alpha Thalassemia Revenue and Growth Rate (2015-2020)
9.4 Egypt Alpha Thalassemia Revenue and Growth Rate (2015-2020)
9.5 South Africa Alpha Thalassemia Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Alpha Thalassemia Revenue and Market Share by Type (2015-2020)
10.2 Global Alpha Thalassemia Market Forecast by Type (2019-2024)
10.3 Iron Chelating Drugs Revenue Growth Rate (2015-2025)
10.4 Gene Therapy Revenue Growth Rate (2015-2025)
11 Global Alpha Thalassemia Market Segment by Application
11.1 Global Alpha Thalassemia Revenue Market Share by Application (2015-2020)
11.2 Alpha Thalassemia Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Private clinics Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Alpha Thalassemia Market Size Forecast (2021-2025)
12.1 Global Alpha Thalassemia Market Size Forecast (2021-2025)
12.2 Global Alpha Thalassemia Market Forecast by Regions (2021-2025)
12.3 North America Alpha Thalassemia Revenue Market Forecast (2021-2025)
12.4 Europe Alpha Thalassemia Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Alpha Thalassemia Revenue Market Forecast (2021-2025)
12.6 South America Alpha Thalassemia Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Alpha Thalassemia Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Alpha Thalassemia Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Alpha Thalassemia by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Alpha Thalassemia Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Alpha Thalassemia Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Bluebird Bio Corporate Information, Location and Competitors
Table 6. Bluebird Bio Alpha Thalassemia Major Business
Table 7. Bluebird Bio Alpha Thalassemia Total Revenue (USD Million) (2017-2018)
Table 8. Bluebird Bio SWOT Analysis
Table 9. Bluebird Bio Alpha Thalassemia Product and Solutions
Table 10. Bluebird Bio Alpha Thalassemia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Acceleron Pharma Corporate Information, Location and Competitors
Table 12. Acceleron Pharma Alpha Thalassemia Major Business
Table 13. Acceleron Pharma Alpha Thalassemia Total Revenue (USD Million) (2018-2019)
Table 14. Acceleron Pharma SWOT Analysis
Table 15. Acceleron Pharma Alpha Thalassemia Product and Solutions
Table 16. Acceleron Pharma Alpha Thalassemia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Novartis Corporate Information, Location and Competitors
Table 18. Novartis Alpha Thalassemia Major Business
Table 19. Novartis Alpha Thalassemia Total Revenue (USD Million) (2017-2018)
Table 20. Novartis SWOT Analysis
Table 21. Novartis Alpha Thalassemia Product and Solutions
Table 22. Novartis Alpha Thalassemia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Kiadis Pharma Corporate Information, Location and Competitors
Table 24. Kiadis Pharma Alpha Thalassemia Major Business
Table 25. Kiadis Pharma Alpha Thalassemia Total Revenue (USD Million) (2017-2018)
Table 26. Kiadis Pharma SWOT Analysis
Table 27. Kiadis Pharma Alpha Thalassemia Product and Solutions
Table 28. Kiadis Pharma Alpha Thalassemia Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Global Alpha Thalassemia Revenue (Million USD) by Players (2015-2020)
Table 30. Global Alpha Thalassemia Revenue Share by Players (2015-2020)
Table 31. Global Alpha Thalassemia Revenue (Million USD) by Regions (2015-2020)
Table 32. Global Alpha Thalassemia Revenue Market Share by Regions (2015-2020)
Table 33. North America Alpha Thalassemia Revenue by Countries (2015-2020)
Table 34. North America Alpha Thalassemia Revenue Market Share by Countries (2015-2020)
Table 35. Europe Alpha Thalassemia Revenue (Million USD) by Countries (2015-2020)
Table 36. Asia-Pacific Alpha Thalassemia Revenue (Million USD) by Countries (2015-2020)
Table 37. South America Alpha Thalassemia Revenue by Countries (2015-2020)
Table 38. South America Alpha Thalassemia Revenue Market Share by Countries (2015-2020)
Table 39. Middle East and Africa Alpha Thalassemia Revenue (Million USD) by Countries (2015-2020)
Table 40. Middle East and Africa Alpha Thalassemia Revenue Market Share by Countries (2015-2020)
Table 41. Global Alpha Thalassemia Revenue (Million USD) by Type (2015-2020)
Table 42. Global Alpha Thalassemia Revenue Share by Type (2015-2020)
Table 43. Global Alpha Thalassemia Revenue Forecast by Type (2021-2025)
Table 44. Global Alpha Thalassemia Revenue by Application (2015-2020)
Table 45. Global Alpha Thalassemia Revenue Share by Application (2015-2020)
Table 46. Global Alpha Thalassemia Revenue Forecast by Application (2021-2025)
Table 47. Global Alpha Thalassemia Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Alpha Thalassemia Picture
Figure 2. Global Alpha Thalassemia Revenue Market Share by Type in 2019
Figure 3. Iron Chelating Drugs Picture
Figure 4. Gene Therapy Picture
Figure 5. Alpha Thalassemia Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Private clinics Picture
Figure 8. Other Picture
Figure 9. Global Alpha Thalassemia Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Alpha Thalassemia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Alpha Thalassemia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Alpha Thalassemia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Alpha Thalassemia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Alpha Thalassemia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Alpha Thalassemia Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Alpha Thalassemia Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Alpha Thalassemia Revenue Market Share in 2019
Figure 18. Global Top 10 Players Alpha Thalassemia Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Alpha Thalassemia Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Alpha Thalassemia Revenue Market Share by Regions (2015-2020)
Figure 22. Global Alpha Thalassemia Revenue Market Share by Regions in 2018
Figure 23. North America Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 24. Europe Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 26. South America Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 28. North America Alpha Thalassemia Revenue Market Share by Countries (2015-2020)
Figure 29. North America Alpha Thalassemia Revenue Market Share by Countries in 2019
Figure 30. USA Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 31. Canada Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 33. Europe Alpha Thalassemia Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Alpha Thalassemia Revenue Market Share by Countries in 2019
Figure 35. Germany Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 36. UK Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 37. France Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 38. Russia Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 39. Italy Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Alpha Thalassemia Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Alpha Thalassemia Revenue Market Share by Countries in 2019
Figure 42. China Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 43. Japan Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 44. Korea Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 45. India Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 47. South America Alpha Thalassemia Revenue Market Share by Countries (2015-2020)
Figure 48. South America Alpha Thalassemia Revenue Market Share by Countries in 2019
Figure 49. Brazil Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Alpha Thalassemia Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Alpha Thalassemia Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 54. UAE Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Alpha Thalassemia Revenue and Growth Rate (2015-2020)
Figure 57. Global Alpha Thalassemia Revenue Share by Type (2015-2020)
Figure 58. Global Alpha Thalassemia Revenue Share by Type in 2019
Figure 59. Global Alpha Thalassemia Market Share Forecast by Type (2021-2025)
Figure 60. Global Iron Chelating Drugs Revenue Growth Rate (2015-2020)
Figure 61. Global Gene Therapy Revenue Growth Rate (2015-2020)
Figure 62. Global Alpha Thalassemia Revenue Share by Application (2015-2020)
Figure 63. Global Alpha Thalassemia Revenue Share by Application in 2019
Figure 64. Global Alpha Thalassemia Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 66. Global Private clinics Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Alpha Thalassemia Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Alpha Thalassemia Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Alpha Thalassemia Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Alpha Thalassemia Revenue Market Forecast (2021-2025)
Figure 72. Europe Alpha Thalassemia Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Alpha Thalassemia Revenue Market Forecast (2021-2025)
Figure 74. South America Alpha Thalassemia Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Alpha Thalassemia Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
アルファマンノシドーシスの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Alpha Mannosidosis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.6% in the forecast period of 2020 to 2025 and will expected to reach USD 7 million by 2025, from USD 5 million in 2019. The Alpha Mannosidosis market r…- α-アミラーゼの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Alpha-Amylase (α-Amylase) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alpha-Amylase (α-Am…
- アルファブロッカーの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Alpha Blockers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alpha Blockers market report p…
- アルファ1アンチトリプシン欠乏症治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Alpha 1 Antitrypsin Deficiency Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.9% in the forecast period of 2020 to 2025 and will expected to reach USD 1433 million by 2025, from USD 1184.2 million in 2019. T…
- アルファビサボロールの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Alpha Bisabolol market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alpha Bisabolol market report…